Marco Tigano, PhD
Assistant Professor
Contact Information
Assistant Professor
Research & Clinical Interests
The coordinated expression of the nuclear and the mitochondrial genome (mtDNA) control mitochondrial function. Mitochondria use complex signaling pathways – retrograde signaling - to communicate with the nucleus about stress and damage and guarantee cellular homeostasis. Persistent mitochondrial dysfunction induced by environmental stressors or mtDNA mutations leads to aberrant retrograde signaling that significantly impacts the progression of a vast repertoire of human disorders by imposing energy constriction, fostering tissue inflammation, and promoting degeneration.
In the lab, we perform foundational research to better understand aberrant mitochondrial signaling by defining its mechanistic aspects, triggering events, and propagation within cells and tissues. We use a wide gamut of genetic models, ranging from acute stress induced by mtDNA damage, inducible models of mtDNA deletions, and CRISPR reconstituted disease models. As a team, we will explore the functional consequences of aberrant mitochondrial stress through targeted experiments and exploratory next-generation -omics approaches.
Education
Education
PhD Biotechnologies, University of Parma, Parma, Italy - 2012
MS Molecular Biology, University of Parma, Parma, Italy - 2008
Fellowship
Post-Doctoral Fellowship, NYU School of Medicine, New York, NY
Most Recent Peer-Reviewed Publications
- Molecular and cellular consequences of mitochondrial DNA double-stranded breaks
- PDE12 mediated pruning of the poly-A tail of mitochondrial DNA-encoded tRNAs is essential for survival
- Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy(Front. Oncol., (2023), 13, (1257622), 10.3389/fonc.2023.1257622)
- Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma
- Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy